2
edits
Difference between revisions of "Malignant melanoma"
Jump to navigation
Jump to search
→Tumour stage
| Line 241: | Line 241: | ||
=====Tumour stage===== | =====Tumour stage===== | ||
Melanoma staging is based primarily on the Breslow thickness:<ref>{{Cite journal | last1 = Nowecki | first1 = ZI. | last2 = Rutkowski | first2 = P. | last3 = Michej | first3 = W. | title = The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). | journal = Ann Surg Oncol | volume = 15 | issue = 8 | pages = 2223-34 | month = Aug | year = 2008 | doi = 10.1245/s10434-008-9965-3 | PMID = 18506535 }}</ref><ref>URL: [ | Melanoma staging is based primarily on the Breslow thickness:<ref>{{Cite journal | last1 = Nowecki | first1 = ZI. | last2 = Rutkowski | first2 = P. | last3 = Michej | first3 = W. | title = The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). | journal = Ann Surg Oncol | volume = 15 | issue = 8 | pages = 2223-34 | month = Aug | year = 2008 | doi = 10.1245/s10434-008-9965-3 | PMID = 18506535 }}</ref><ref>URL: [https://documents.cap.org/protocols/Skin.Melanoma.Bx_4.3.0.1.REL_CAPCP.pdf https://documents.cap.org/protocols/Skin.Melanoma.Bx_4.3.0.1.REL_CAPCP.pdf]. Accessed on: 14 September 2021.</ref> | ||
*pT1 ≤ 1.0 mm. | *pT1 ≤ 1.0 mm. | ||
**pT1a: ≤ 0.8 mm, no ulceration. | **pT1a: ≤ 0.8 mm, no ulceration. | ||